# Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation

> **NCT03958344** · PHASE3 · UNKNOWN · sponsor: **Iran University of Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Orbital Pseudotumor

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** Triamcinolone + Betamethason

## Key facts

- **NCT ID:** NCT03958344
- **Lead sponsor:** Iran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03958344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03958344, "Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03958344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*